Skip to main content
Journal cover image

Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients.

Publication ,  Conference
Peters, KB; Kirkpatrick, J; Batinic-Haberle, I; Affronti, ML; Woodring, S; Iden, D; Lipp, ES; Healy, P; Herndon, JE; Boyd, K; Hahn, K; Gad, S ...
Published in: Supportive Care in Cancer
2020

MASCC20-ABS-1534

Duke Scholars

Published In

Supportive Care in Cancer

ISSN

0941-4355

Publication Date

2020

Location

Seville, Spain

Publisher

Springer (part of Springer Nature)

Conference Name

2020 MASCC/ISOO Annual Meeting

Related Subject Headings

  • Oncology & Carcinogenesis
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 17 Psychology and Cognitive Sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peters, K. B., Kirkpatrick, J., Batinic-Haberle, I., Affronti, M. L., Woodring, S., Iden, D., … Crapo, J. (2020). Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients. In Supportive Care in Cancer. Seville, Spain: Springer (part of Springer Nature).
Peters, Katherine B., John Kirkpatrick, I. Batinic-Haberle, Mary L. Affronti, Sarah Woodring, Deborah Iden, Eric S. Lipp, et al. “Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients.” In Supportive Care in Cancer. Springer (part of Springer Nature), 2020.
Peters KB, Kirkpatrick J, Batinic-Haberle I, Affronti ML, Woodring S, Iden D, et al. Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients. In: Supportive Care in Cancer. Springer (part of Springer Nature); 2020.
Peters, Katherine B., et al. “Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients.Supportive Care in Cancer, Springer (part of Springer Nature), 2020.
Peters KB, Kirkpatrick J, Batinic-Haberle I, Affronti ML, Woodring S, Iden D, Lipp ES, Healy P, Herndon JE, Boyd K, Hahn K, Spasojevic I, Gad S, Silberstein D, Johnson MO, Randazzo D, Desjardins A, Friedman HS, Ashley D, Crapo J. Cognitive Outcomes of Phase I Trial of Novel Metalloporphyrin Radioprotectant and Radiosensitizer in Newly Diagnosed High Grade Glioma Patients. Supportive Care in Cancer. Springer (part of Springer Nature); 2020.
Journal cover image

Published In

Supportive Care in Cancer

ISSN

0941-4355

Publication Date

2020

Location

Seville, Spain

Publisher

Springer (part of Springer Nature)

Conference Name

2020 MASCC/ISOO Annual Meeting

Related Subject Headings

  • Oncology & Carcinogenesis
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 17 Psychology and Cognitive Sciences
  • 11 Medical and Health Sciences